Browse studies

Find your next paid study

6 recruiting studies matching your filters

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeutic-dose h…

Community-acquired Pneumonia

Estimated

~$10 – $6,250

University of ManitobaNCT05848713

Phase 4

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneu…

Community-acquired Pneumonia

Estimated

~$10 – $6,250

Mayo ClinicNCT07164131

Phase 3

A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Hospitalized Subjects With Severe Community-acquired Pneumonia (sCAP)

The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus S…

Community-acquired Pneumonia

Estimated

~$10 – $7,500

BiotestNCT05722938

Relative Vaccine Effectiveness of Adjuvanted Inactivated Influenza Vaccine (aIIV) vs High-Dose Inactivated Influenza Vaccine (HD-IIV) for Prevention of Lab-Confirmed Influenza Among Adults ≥65 Years of Age in the United States

This study will evaluate the relative vaccine effectiveness of quadrivalent adjuvanted inactivated influenza vaccine (aIIV4) versus quadrivalent high-dose inac…

InfluenzaCommunity-acquired PneumoniaCardiovascular Events

Estimated

~$10 – $7,500

Kaiser PermanenteNCT06029933

Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the ef…

Community-acquired Pneumonia, Influenza, COVID-19

Estimated

~$10 – $7,500

UMC UtrechtNCT02735707

Observational

Neuromuscular Electrical Stimulation (NMES) in Patients Hospitalized With Acute Exacerbation of COPD and/or Community Acquired Pneumonia

In older adults hospitalized for acute medical conditions, immobility, clinical treatments, and the illness itself contribute to physical deconditioning and de…

Community-acquired PneumoniaCOPD Exacerbation Acute

Estimated

~$10 – $6,250

University of VermontNCT05452226